Senior Manager, Investor Relations

Tarrytown, NY, United States
Oct 12, 2020
Required Education
Position Type
Full time
Regeneron is seeking a Senior Manager, Investor Relations for our Tarrytown, NY location. Assist in the development and execution of Regenerons Investor Relations strategy, which includes strategic positioning and dissemination of the Companys corporate message, interactions with the investment community and identifying and targeting key investor groups, both in the U.S. and globally. Interface with the investment community while serving as a credible and timely source of information. Assist in the development of strategies to target select investors and funds in order to expand stock ownership base, both in the U.S. and on a global basis. Support the Companys Investor Relations strategic programs. Work with Senior Management and various internal stakeholders to develop and refine strategic communications delivered to investors and analysts. Liaise with Corporate Communications and the Controllers department on materials such as press releases and earnings releases, for dissemination to the public. Liaise with external stakeholders, including investors and financial analysts as well as key opinion leaders in healthcare practice.

Must possess a PhD degree or foreign equivalent in Molecular & Integrative Physiology or related scientific field and 2 years of experience in consulting, banking, finance or equity research. Must have defended a PhD thesis in the field of oncology, immunology, or neuroscience. Must possess 2 years of experience with the following research techniques: flow cytometry, ELISA, Western blot, cell culture, retroviral transduction, fluorescence microscopy, immunohistochemistry, molecular cloning; and laboratory research-related software including: Graphpad Prism, FCS Express, and Vector NTI; and working with laboratory animals. Must possess 1 year of experience with: healthcare consulting, focusing on oncology, inflammatory, and rare diseases; conducting market research, designing presentations and final deliverables to clients; with the following applications and services: Evaluate Pharma, Thomson Reuters, TrialTracker; in the financial industry, including investment banking or equity research; building and updating financial models, including DCF and EPS multiple-based evaluation; analyzing and deriving information from SEC filings and other financial reports; using the following applications and services: FactSet, BiomedTracker, UpToDate, BlueMatrix, Bloomberg terminal; and attending and reporting on scientific conferences. Must have passed following exams for securities professionals administered by Financial Industry Regulatory Authority (FINRA): Series 7, Series 63, Series 86, and Series 87. Must have published oncology or immunology-themed research in peer-reviewed journals. Must have published research reports on publicly-traded companies in the biotechnology sector. Must have attended and reported from scientific conferences. Up to 15% international and domestic travel required.

To apply, please mail resume to Robin Eisenman, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591. Please reference requisition code 21377BR when applying. #LI-DNI, #GD-DNI, #IN-DNI